Single-institution clinical experience using robust intensity modulated proton therapy in chordoma and chondrosarcoma of the mobile spine and sacrum: Feasibility and need for plan adaptation: Robust planning in chordoma of spine and sacrum

Michiel Kroesen*, Vesna Miladinovic, Stefan A.J. Hutschemaekers, Jenneke Jacobs, Charlotte van der Vos, Anne Lisa Wolf, Mischa S. Hoogeman, Marco van Vulpen, Johan L. Bloem, Sander P.D.S. Dijkstra, Wilco C. Peul, Joan J. Penninkhof, Augustinus D.G. Krol

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
45 Downloads (Pure)

Abstract

Background: Due to its specific physical characteristics, proton irradiation is especially suited for irradiation of chordomas and chondrosarcoma in the axial skeleton. Robust plan optimization renders the proton beam therapy more predictable upon individual setup errors. Reported experience with the planning and delivery of robustly optimized plans in chordoma and chondrosarcoma of the mobile spine and sacrum, is limited. In this study, we report on the clinical use of robustly optimized, intensity modulated proton beam therapy in these patients. Methods: We retrospectively reviewed patient, treatment and acute toxicity data of all patients with chordoma and chondrosarcoma of the mobile spine and sacrum, treated between 1 April 2019 and 1 April 2020 at our institute. Anatomy changes during treatment were evaluated by weekly cone-beam CTs (CBCT), supplemented by scheduled control-CTs or ad-hoc control-CTs. Acute toxicity was scored weekly during treatment and at 3 months after therapy according to CTCAE 4.0. Results: 17 chordoma and 3 chondrosarcoma patients were included. Coverage of the high dose clinical target volume was 99.8% (range 56.1–100%) in the nominal and 80.9% (range 14.3–99.6%) in the voxel-wise minimum dose distribution. Treatment plan adaptation was needed in 5 out of 22 (22.7%) plans. Reasons for plan adaptation were either reduced tumor coverage or increased dose to the OAR. Conclusions: Robustly optimized intensity modulated proton beam therapy for chordoma and chondrosarcoma of the mobile spine is feasible. Plan adaptations due to anatomical changes were required in approximately 23 percent of treatment courses.

Original languageEnglish
Pages (from-to)58-64
Number of pages7
JournalRadiotherapy and Oncology
Volume166
Early online date26 Nov 2021
DOIs
Publication statusPublished - Jan 2022

Bibliographical note

Publisher Copyright:
© 2021

Fingerprint

Dive into the research topics of 'Single-institution clinical experience using robust intensity modulated proton therapy in chordoma and chondrosarcoma of the mobile spine and sacrum: Feasibility and need for plan adaptation: Robust planning in chordoma of spine and sacrum'. Together they form a unique fingerprint.

Cite this